1. NF-κB PI3K/Akt/mTOR Apoptosis Cell Cycle/DNA Damage Epigenetics
  2. IKK Akt Apoptosis PI3K NF-κB CDK Caspase PARP
  3. LIB3S0280

LIB3S0280 is a potent TBK1 inhibitor with an IC50 value of 493.9 nM. LIB3S0280 exhibits better anticancer effects in pancreatic cancer cell lines with high TBK1 expression. LIB3S0280 inhibits TBK1 downstream signaling pathways, including PI3K/AKT and NF-κB. LIB3S0280 induces G2/M arrest, apoptosis and cellular senescence. LIB3S0280 can be used for pancreatic ductal adenocarcinoma (PDAC) research.

For research use only. We do not sell to patients.

LIB3S0280

LIB3S0280 Chemical Structure

Size Price Stock Quantity
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

LIB3S0280 is a potent TBK1 inhibitor with an IC50 value of 493.9 nM. LIB3S0280 exhibits better anticancer effects in pancreatic cancer cell lines with high TBK1 expression. LIB3S0280 inhibits TBK1 downstream signaling pathways, including PI3K/AKT and NF-κB. LIB3S0280 induces G2/M arrest, apoptosis and cellular senescence. LIB3S0280 can be used for pancreatic ductal adenocarcinoma (PDAC) research[1].

IC50 & Target[1]

TBK1

493.9 nM (IC50)

In Vitro

LIB3S0280 (72-96 h) shows significant inhibition against high TBK1-expressing pancreatic cancer cell lines with the GI50 values of 2.24 μM (MIA PaCa-2) and 4.71 μM (PANC-1) , and IC50 values of 6.64 μM (MIA PaCa-2) and 10.98 μM (PANC-1) at 96 h[1].
LIB3S0280 (10-20 μM, 3 h) inhibits TBK1 downstream signaling, including the PI3K/AKT and NF-κB pathways, by effectively reducing the phosphorylation of its key targets, AKT (Ser473) and IκBα, in MIA PaCa-2 and PANC-1 cells[1].
LIB3S0280 (10-20 μM, 48-96 h) induces G₂/M arrest, apoptosis, and cellular senescence in pancreatic cancer cells (MIA PaCa-2 and PANC-1) by modulating key regulators like p-cdc2, p-MPM2, cyclin B1, and p21[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: MIA PaCa-2 and PANC-1 cells
Concentration: 10 and 20 μM
Incubation Time: 3, 48, 72 and 96 h
Result: Decreased the phosphorylation of IκBα in a dose-dependent manner.
Reduced the phosphorylation level of AKT on the ser473 site.
Increased p21 levels from 48 h to 96 h.

Cell Viability Assay[1]

Cell Line: MIA PaCa-2, PANC-1, and SW1990 cells
Concentration: 10 μM
Incubation Time: 72 and 96 h
Result: Significantly inhibited cell proliferation and cell viability in a concentration-dependent manner, with efficacy comparable to BX-795 (HY-10514).
Demonstrated greater potency against the MIA PaCa-2 cell line.
Showed no inhibition in SW1990 cells.

Cell Cycle Analysis[1]

Cell Line: MIA PaCa-2 and PANC-1 cells
Concentration: 10 and 20 μM
Incubation Time: 48, 72 and 96 h
Result: Significantly increased the G2/M phase population and slightly increased the sub-G1 population at 48 h.
Downregulated the expression level of p-MPM2, and upregulated p-cdc2 (tyr15) and cyclin B1 levels after 48 h.
Slightly decreased the G2/M population but increased sub-G1 population at 72 h, compared to 48 h.
Exhibited a significant increase in the sub-G1 population and a further decrease in the G2/M phase at 96 h.

Apoptosis Analysis[1]

Cell Line: MIA PaCa-2 and PANC-1 cells
Concentration: 10 and 20 μM
Incubation Time: 48, 72 and 96 h
Result: Induced apoptosis at 72-96 h.
Slightly increased cleaved PARP and cleaved caspase 3 levels after 48 h.
Increased the granularity in MIA PaCa-2 and PANC-1 cells at 48 h, 72 h, and 96 h.
Induced senescence in MIA PaCa-2 and PANC-1 cells.
Molecular Weight

460.91

Formula

C22H25ClN4O5

Appearance

Solid

Color

Off-white to gray

SMILES

OC1=C(OC)C=C(CCNC2=NC(NC3=CC(OC)=C(OC)C(OC)=C3)=NC=C2Cl)C=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 50 mg/mL (108.48 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1696 mL 10.8481 mL 21.6962 mL
5 mM 0.4339 mL 2.1696 mL 4.3392 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.1696 mL 10.8481 mL 21.6962 mL 54.2405 mL
5 mM 0.4339 mL 2.1696 mL 4.3392 mL 10.8481 mL
10 mM 0.2170 mL 1.0848 mL 2.1696 mL 5.4241 mL
15 mM 0.1446 mL 0.7232 mL 1.4464 mL 3.6160 mL
20 mM 0.1085 mL 0.5424 mL 1.0848 mL 2.7120 mL
25 mM 0.0868 mL 0.4339 mL 0.8678 mL 2.1696 mL
30 mM 0.0723 mL 0.3616 mL 0.7232 mL 1.8080 mL
40 mM 0.0542 mL 0.2712 mL 0.5424 mL 1.3560 mL
50 mM 0.0434 mL 0.2170 mL 0.4339 mL 1.0848 mL
60 mM 0.0362 mL 0.1808 mL 0.3616 mL 0.9040 mL
80 mM 0.0271 mL 0.1356 mL 0.2712 mL 0.6780 mL
100 mM 0.0217 mL 0.1085 mL 0.2170 mL 0.5424 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
LIB3S0280
Cat. No.:
HY-172620
Quantity:
MCE Japan Authorized Agent: